Research Topics
| R M BonelliSummaryAffiliation: Medical University of Graz Country: Austria Publications
| Collaborators
|
Detail Information
Publications
Huntington's disease: present treatments and future therapeutic modalitiesRaphael M Bonelli
University Clinic of Psychiatry, Karl Franzens University Graz, Graz University Clinic of Neurology, University of Innsbruck, Innsbruck, Austria
Int Clin Psychopharmacol 19:51-62. 2004..Finally, some cellular mechanisms are discussed in this paper because they are essential for future neuroprotective modalities, such as minocycline, unsaturated fatty acids or riluzole...
A review of the treatment options for Huntington's diseaseRaphael M Bonelli
University of Clinic of Psychiatry, Karl Franzens University Graz, Graz, Austria
Expert Opin Pharmacother 5:767-76. 2004..Psychiatric symptoms, on the other hand, are often amenable to treatment and relief of these symptoms may provide significant improvement in quality of life...
Neuroprotection in Huntington's disease: a 2-year study on minocyclineRaphael M Bonelli
Department of Psychiatry, Graz Medical University, Graz, Austria
Int Clin Psychopharmacol 19:337-42. 2004..A long-term, double-blind, placebo-controlled trial appears highly warranted for definitively establishing the value of minocycline in HD...
The influence of psychotropic drugs on cerebral cell death: female neurovulnerability to antipsychoticsRaphael M Bonelli
University Clinic of Psychiatry, Graz Medical University, Graz, Austria
Int Clin Psychopharmacol 20:145-9. 2005..Finally, the possible connection between the observed increased cerebral cell death and tardive dyskinesia, the most threatening side-effect in antipsychotic therapy, is discussed...
Ziprasidone in Huntington's disease: the first case reportsRaphael M Bonelli
University Clinic of Psychiatry, Karl Franzens University Graz, Austria
J Psychopharmacol 17:459-60. 2003..We report three genetically confirmed HD patients who improved significantly in several categories of the motor scale of the Unified HD Rating Scale...
Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years?R M Bonelli
University Clinic of Psychiatry, Graz Medical University, Graz, Austria
J Neural Transm 113:255-68. 2006....
Pharmacological management of Huntington's disease: an evidence-based reviewRaphael M Bonelli
University Clinic of Psychiatry, Department of Psychiatry, Graz Medical University, Auenbruggerplatz 31, A 8036 Graz, Austria
Curr Pharm Des 12:2701-20. 2006..Despite the increasing body of published reports on pharmacological interventions in Huntington's disease (HD), an evidence based review (EBR) of treatment studies has not yet been published...
A systematic review of the treatment studies in Huntington's disease since 1990Raphael M Bonelli
University Clinic of Psychiatry, Graz Medical University, Auenbruggerplatz 31, A 8036 Graz, Austria
Expert Opin Pharmacother 8:141-53. 2007..The authors conducted a systematic review of pharmacological therapy in HD using the available papers that were published between 1990 and 2006...
Frontal-subcortical circuitry and behaviorRaphael M Bonelli
Department of Psychiatry, Graz Medical University, Auenbruggerplatz 31, 8036 Graz, Austria
Dialogues Clin Neurosci 9:141-51. 2007....
Apraxia of eyelid closure in Huntington's diseaseR M Bonelli
Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Graz, Austria
J Neural Transm 109:197-201. 2002..No report on HD is available so far, although oculomotor disturbances are quite common in this disease...
Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XRAnna K Holl
University Clinic of Psychiatry bUniversity Clinic of Neurosurgery, Graz Medical University, Auenbruggerplatz 31, Graz, Austria
Int Clin Psychopharmacol 25:46-50. 2010..Venlafaxine XR is highly effective in the treatment of depression in HD, although it may produce unpleasant side effects. Further studies are required to establish the most suitable treatment for depression in HD...
Pramipexole ameliorates neurologic and psychiatric symptoms in a Westphal variant of Huntington's diseaseRaphael M Bonelli
Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Graz, Austria
Clin Neuropharmacol 25:58-60. 2002..In this study, however, we report a 34-year-old woman with this rare variant who showed a clear-cut improvement in motor function and depressive symptoms after treatment with pramipexole, a new dopamine agonist...
Compactotomy in Huntington's choreaR M Bonelli
Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Graz, Austria
Med Hypotheses 57:491-6. 2001..Several lines of evidence in recent neurophysiological research support our hypothesis and are discussed below...
High-dose olanzapine in Huntington's diseaseR M Bonelli
Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Graz, Austria
Int Clin Psychopharmacol 17:91-3. 2002..This effect lasted for 5 months. We conclude that high-dose olanzapine appears to be useful in grave choreatic attacks...
Sexuality in multiple sclerosisE Z Schmidt
University Clinic of Psychiatry, Medical University of Graz, Graz, Austria
J Neural Transm 112:1201-11. 2005..Positive familial support can often help the patient in coping with the illness, nonetheless problems with changing roles and multiple-sclerosis-minimizing can improve the need of contacts to outstanding persons...
Ideomotor limb apraxia in Huntington's disease: a case-control studyAnna K Hödl
University Clinic of Psychiatry, Graz Medical University, Auenbruggerplatz 31, 8036, Graz, Austria
J Neurol 255:331-9. 2008..The aim of our study is to determine the correlation between the occurrence of ideomotor limb apraxia and neuropsychological deficits in HD...
Structural neuroimaging of the basal ganglia in schizophrenic patients: a reviewGerrit N Brandt
Department of Psychiatry, Medical University of Graz, Graz, Austria
Wien Med Wochenschr 158:84-90. 2008..Further studies are warranted for a better understanding of the mechanisms, which may lead to structural basal ganglia abnormalities, with medication effects demanding particular attention...
Sexuality in Huntington's diseaseEva Z Schmidt
Department of Psychiatry, Medical University of Graz, Graz, Austria
Wien Med Wochenschr 158:78-83. 2008..Treatment options for HD patients with sexual disorder are only reported sporadically, guidelines can only be obtained from non-HD patients and further research is needed...
Olanzapine for Huntington's disease: an open label studyRaphael M Bonelli
Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Graz, Austria
Clin Neuropharmacol 25:263-5. 2002..High-dose olanzapine seems to be useful in choreatic HD patients. A double blind, placebo-controlled trial appears warranted to definitively establish the symptomatic value of olanzapine in HD...
Minocycline for Huntington's disease: an open label studyRaphael M Bonelli
Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Graz, Austria
Neurology 60:883-4. 2003
Amantadine in the akinetic-rigid variant of Huntington's diseaseMarkus K Magnet
Karl-Franzens University Graz, Graz, Austria
Ann Pharmacother 38:1194-6. 2004..Fine-motor tasks and eye movement did not change significantly. CONCLUSIONS: We suggest that amantadine treatment might be of value to patients with the akinetic-rigid variant of HD...
Cerebrospinal fluid tissue transglutaminase in vascular dementiaRaphael M Bonelli
Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Bergstrasse 27, A 8021 Graz, Austria
J Neurol Sci 203:207-9. 2002..It may serve as completion of CSF analysis in diagnosis of dementing disorders and be a simple way of assessing the efficacy of possible new anti-apoptotic drugs...
Zotepine in Huntington's diseaseRaphael M Bonelli
Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Bergstrasse 27, A 8021 Graz, Austria
Hum Psychopharmacol 18:227-9. 2003..This is the first description of zotepine in HD. Our findings suggest that zotepine is useful in the treatment of HD chorea. Controlled trials of its use in HD would be welcome...
Riluzole and olanzapine in Huntington's diseaseRaphael M Bonelli
Eur J Neurol 9:183-4. 2002
Huntington's disease and minocyclineAnna K Hödl
Mov Disord 20:510-1; author reply 511. 2005
Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's diseaseRaphael M Bonelli
Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Bergstrasse 27, A 8021 Graz, Austria
Neurobiol Dis 11:106-10. 2002..It may serve as completion of CSF analysis in the diagnosis of dementing disorders and may be a simple way of assessing the efficacy of possible new antiapoptotic drugs...
Deep brain stimulation in Huntington's diseaseRaphael M Bonelli
Mov Disord 17:429-30; author reply 431-2. 2002
Mirtazapine in suicidal Huntington's diseaseRaphael M Bonelli
Ann Pharmacother 37:452. 2003
Drug holiday in Huntington's diseaseEva Z Schmidt
Ann Pharmacother 39:773. 2005
Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosisGerald Niederwieser
Department of Neurology, Barmherzige Brüder Hospital, Bergstrasse 27, 8021 Graz, Austria
J Neurol 250:672-5. 2003..Longitudinal studies comparing MS patients with or without AIT could show whether there is an influence of AIT on the disease course or progression...
Olanzapine-associated seizureRaphael M Bonelli
Ann Pharmacother 37:149-50. 2003
Quetiapine in Huntington's disease: a first case reportRaphael M Bonelli
J Neurol 249:1114-5. 2002
Apoptotic cascades as possible targets for inhibiting cell death in Huntington's diseaseLindsay R Pattison
Department of Biochemistry and Molecular Biology, The College of Wooster, 1189 Beall Avenue, Wooster, OH 44691, USA
J Neurol 253:1137-42. 2006....
Cortical blood flow during rest and Wisconsin Card Sorting Test performance in schizophreniaFelipe Ortuno
University Clinic of Psychiatry, University of Navarra College of Medicine, Pamplona, Spain
Wien Med Wochenschr 156:179-84. 2006..The aim of this study is to examine if patients with schizophrenia differ in prefrontal, orbitofrontal, temporal, parietal and occipital blood flow from healthy controls during performance of the Wisconsin Card Sorting Test (WCST)...
Why minocycline is helpful in Huntington's diseaseRaphael M Bonelli
J Psychopharmacol 17:461. 2003
